Article Information
PubMed
Published By
Online ISSN
History
- Received May 20, 2020
- Revision received July 15, 2020
- Accepted July 15, 2020
- Published online July 23, 2020.
Copyright & Usage
© 2020 Bestle et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Author Information
- Dorothea Bestle1,*,
- Miriam Ruth Heindl1,*,
- Hannah Limburg1,*,
- Thuy Van Lam van2,
- Oliver Pilgram2,
- Hong Moulton3,
- David A Stein3,
- Kornelia Hardes2,4,
- Markus Eickmann1,5,
- Olga Dolnik1,5,
- Cornelius Rohde1,5,
- Hans-Dieter Klenk1,
- Wolfgang Garten1,
- Torsten Steinmetzer2 and
- Eva Böttcher-Friebertshäuser1⇑
- 1Institute of Virology, Philipps-University, Marburg, Germany
- 2Institute of Pharmaceutical Chemistry, Philipps-University, Marburg, Germany
- 3Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA
- 4Fraunhofer Institute for Molecular Biology and Applied Ecology, Gießen, Germany
- 5German Center for Infection Research (DZIF), Marburg-Gießen-Langen Site, Emerging Infections Unit, Philipps-University, Marburg, Germany
- Correspondence: friebertshaeuser{at}staff.uni-marburg.de
↵* Dorothea Bestle, Miriam Ruth Heindl, and Hannah Limburg contributed equally to this work
Funding
LOEWE Center DRUID
D1Deutsche Forschungsgemeinschaft (DFG)
SFB 1021, B07German Center for Infection Research (DZIF)
TMPRSS2 and furin activate SARS-CoV-2
In this Issue
Advertisement
Related Articles
Cited By...
- A diabetic milieu increases cellular susceptibility to SARS-CoV-2 infections in engineered human kidney organoids and diabetic patients
- Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
- A method for the generation of pseudotyped virus particles bearing SARS coronavirus spike protein in high yields
- FXa cleaves the SARS-CoV-2 spike protein and blocks cell entry to protect against infection with inferior effects in B.1.1.7 variant
- The Furin-S2' Site in Avian Coronavirus Plays a Key Role in Central Nervous System Damage Progression
- The PRRA Insert at the S1/S2 Site Modulates Cellular Tropism of SARS-CoV-2 and ACE2 Usage by the Closely Related Bat RaTG13
- On the Origin of SARS-CoV-2: Did Cell Culture Experiments Lead to Increased Virulence of the Progenitor Virus for Humans?
- SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction
- Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
- Large fluctuations of the fusion intermediate help SARS-CoV-2 capture host cell membranes
- Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin
- Structural basis for GTP-induced dimerization and antiviral function of guanylate-binding proteins
- Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza
- Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
- Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza
- SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity
- Spike Protein of SARS-CoV-2 Activates Macrophages and Contributes to Induction of Acute Lung Inflammations in Mice
- The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo
- A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro
- The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways
- Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut
- Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19
- A Tethered Ligand Assay to Probe the SARS-CoV-2 ACE2 Interaction under Constant Force